rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2007-2-21
|
pubmed:abstractText |
Gliomatosis cerebri is a rare brain tumor with a short survival time; for this reason, it is difficult to establish the degree of aggressivity in vivo. The MR spectroscopic findings on this tumor often do not agree with choline level. The purpose of this study was to evaluate whether MR spectroscopy can be used to measure tumor choline levels and whether the findings give useful information about tumor growth rate and patient survival time.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1546-3141
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
188
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
710-4
|
pubmed:dateRevised |
2008-2-15
|
pubmed:meshHeading |
pubmed-meshheading:17312058-Aspartic Acid,
pubmed-meshheading:17312058-Brain Neoplasms,
pubmed-meshheading:17312058-Choline,
pubmed-meshheading:17312058-Humans,
pubmed-meshheading:17312058-Magnetic Resonance Imaging,
pubmed-meshheading:17312058-Magnetic Resonance Spectroscopy,
pubmed-meshheading:17312058-Neoplasms, Neuroepithelial,
pubmed-meshheading:17312058-Protons,
pubmed-meshheading:17312058-Tumor Markers, Biological
|
pubmed:year |
2007
|
pubmed:articleTitle |
1H MR spectroscopy in the assessment of gliomatosis cerebri.
|
pubmed:affiliation |
Department of Neuroradiology, Hospital General Universitario Gregorio Marañón, Madrid, Spain 28007.
|
pubmed:publicationType |
Journal Article
|